Db07107
Modify Date: 2025-08-26 08:39:41
Db07107 structure
|
Common Name | Db07107 | ||
|---|---|---|---|---|
| CAS Number | 552332-71-5 | Molecular Weight | 370.45 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C23H22N4O | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Db07107DB07107 is a potent drug resistant T315I mutant Bcr-Abl tyrosine kinase inhibitor. DB07107 is also a potent Akt1 inhibitor with an IC50 value of 360 nM[1][2]. |
| Name | DB07107 |
|---|
| Description | DB07107 is a potent drug resistant T315I mutant Bcr-Abl tyrosine kinase inhibitor. DB07107 is also a potent Akt1 inhibitor with an IC50 value of 360 nM[1][2]. |
|---|---|
| Related Catalog | |
| Target |
Bcr-AblT315I Akt1:360 nM (IC50) |
| In Vitro | DB07107 is more effective in blocking drug-resistant T315I mutant than the wild-type Bcr-Abl. DB07107 (C23H22N4O) from DrugBank showed the highest binding energy with XP score of -14.045 kcal/mol[1]. |
| References |
| Molecular Formula | C23H22N4O |
|---|---|
| Molecular Weight | 370.45 |
| Hazard Codes | Xi |
|---|